ArticleThe Journal of urology2020

Re: A Cost-Utility Analysis of Phosphodiesterase Type 5 Inhibitors in the Treatment of Erectile Dysfunction.

Allen D SeftelPubMed ↗Publisher ↗

No numbers read from the abstract.